Andrew Hirsch
2016 - Agios Pharmaceuticals
In 2016, Andrew Hirsch earned a total compensation of $5.2M as Chief Financial Officer and Head of Corporate Development at Agios Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $176,000 |
|---|---|
| Option Awards | $4,186,746 |
| Salary | $126,667 |
| Stock Awards | $747,450 |
| Other | $698 |
| Total | $5,237,561 |
Hirsch received $4.2M in option awards, accounting for 80% of the total pay in 2016.
Hirsch also received $176K in non-equity incentive plan, $126.7K in salary, $747.5K in stock awards and $698 in other compensation.
Rankings
In 2016, Andrew Hirsch's compensation ranked 1,504th out of 14,075 executives tracked by ExecPay. In other words, Hirsch earned more than 89.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,504 out of 14,075 | 89th |
Division Manufacturing | 514 out of 5,489 | 91st |
Major group Chemicals And Allied Products | 145 out of 1,895 | 92nd |
Industry group Drugs | 99 out of 1,538 | 94th |
Industry Pharmaceutical Preparations | 79 out of 1,176 | 93rd |
Source: SEC filing on April 18, 2018.
Hirsch's colleagues
We found five more compensation records of executives who worked with Andrew Hirsch at Agios Pharmaceuticals in 2016.
2016
Steve Hoerter
Agios Pharmaceuticals
Chief Commercial Officer
2016
David Schenkein
Agios Pharmaceuticals
Chief Executive Officer
2016
Christopher Bowden
Agios Pharmaceuticals
Chief Medical Officer
2016
Scott Biller
Agios Pharmaceuticals
Chief Scientific Officer
2016
Glenn Goddard
Agios Pharmaceuticals